Search

everythinglearnresearchcommunity

for

Search:↓

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Calancardin B may help reduce inflammation in immune cells.

Quercitrin may help treat Alzheimer's by boosting brain cell signaling without causing tumors.

Removing certain brain receptors in mice worsens seizure severity and response to treatment during hormone withdrawal.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Croton membranaceus root extract can change how drugs are processed in the body.

11β-Hydroxylase inhibitors help prevent seizures in mice by boosting natural neurosteroid production.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

High doses of TCB cause severe health issues in marmoset monkeys.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Neuroactive steroids affect cocaine's rewarding effects through the sigma1 receptor.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Baricitinib can cause excessive hair growth.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

The treatment was ineffective in humans.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Baricitinib helps with early hair regrowth in people with alopecia areata.